NCT06069726 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06069726
Title	A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial (MOAB)
Acronym	MOAB
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Duke University
Indications	IDH-wildtype glioblastoma
Therapies	Atezolizumab
Age Groups:	senior \| adult
Covered Countries	USA

Filter rows:

Showing 1 to 3 of 3 entries

Facility	Status	City	State	Zip	Country	Details
Duke University	RECRUITING	Durham	North Carolina	27705	United States	Details
Huntsman Cancer Institute	RECRUITING	Salt Lake City	Utah	84112	United States	Details
Saint Luke's Cancer Institute	RECRUITING	Kansas City	Missouri	64111	United States	Details

Showing 1 to 3 of 3 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06069726Clinical Trial Detail